Viking Therapeutics Inc. (VKTX)
NASDAQ · Healthcare
Viking Therapeutics Inc. Total Liabilities 2014–2025
Viking Therapeutics Inc. annual/quarterly total liabilities history from 2014 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Viking Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 76.7M, a 173.39% increase year-over-year.
- Viking Therapeutics Inc. total liabilities for 2025 were 76.7M, a 173.39% increase from 2024.
- Viking Therapeutics Inc. total liabilities for 2024 were 28.0M, a 39.72% increase from 2023.
- Viking Therapeutics Inc. total liabilities for 2023 were 20.1M, a 13.51% decrease from 2022.
- Viking Therapeutics Inc. total liabilities for 2022 were 23.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Viking Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $77 |
| 2024 | $28 |
| 2023 | $20 |
| 2022 | $23 |
| 2021 | $9 |
| 2020 | $12 |
| 2019 | $7 |
| 2018 | $5 |
| 2017 | $9 |
| 2016 | $6 |
| 2015 | $7 |
| 2014 | $25 |
| Viking Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $77 |
| 2024-12-31 | $28 |
| 2023-12-31 | $20 |
| 2022-12-31 | $23 |
| 2021-12-31 | $9 |
| 2020-12-31 | $12 |
| 2019-12-31 | $7 |
| 2018-12-31 | $5 |
| 2017-12-31 | $9 |
| 2016-12-31 | $6 |
| 2015-12-31 | $7 |
| 2014-12-31 | $25 |
Viking Therapeutics Inc. Total Liabilities — FAQ
Viking Therapeutics Inc. (VKTX) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VKTX's total liabilities history?
The chart and table above show Viking Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.